Masimo Corporation (MASI)

133,57 -2,35 (-1,73%) In data: 11:59AM EDT. Mercato aperto.

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000
https://www.masimo.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 3.800

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Joseph E. Kiani	Founder, CEO & Chairman	3,31M	N/D	1965
Mr. Micah Young	Executive VP & CFO	1,13M	N/D	1979
Mr. Bilal Muhsin	Chief Operating Officer	1,2M	N/D	1981
Mr. Thomas Samuel McClenahan	Executive VP, General Counsel & Corporate Secretary	957,51k	N/D	1973
Mr. Tao Leopold Levy	Executive Vice President of Business Development	798,52k	N/D	1974
Mr. Paul Hataishi	Senior VP & Chief Accounting Officer	N/D	N/D	1975
Mr. Yongsam Lee	Executive VP & Chief Information Officer	1,1M	1,2M	1965
Dr. Steven J. Barker	Chairman of Scientific Advisory Board & Chief Science Officer	139,56k	N/D	1945
Mr. Eli Kammerman	Vice President of Business Development & Investor Relations	N/D	N/D	N/D
Mr. Jon Coleman	President of Worldwide Sales, Professional Services & Medical Affairs	584,59k	5,57M	1964

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Governance aziendale

L'ISS Governance QualityScore di Masimo Corporation al 1 aprile 2024 è 5. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 8; diritti degli azionisti: 3; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.